Article 1 to 2 out of 2 concerning Cambridge Antibody Technology Group plc
AstraZeneca to acquire MedImmune for $15.2 billion(25 Apr 2007) AstraZeneca PLC announced that it has entered into a definitive agreement to acquire MedImmune, Inc. in an all-cash transaction. Under the terms of the agreement, which has unanimous MedImmune Board support, AstraZeneca will acquire all of the fully ...
Danisco sells part of Genencor's Health Care product portfolio(03 Nov 2005) Danisco sells part of Genencor's Health Care activities to Cambridge Antibody Technology (CAT) for USD 14 million. On closing, Danisco will hold USD 14 million in shares in CAT subscribed at market price. The CAT shares that Danisco will receive are ...
Top